Table 1. Comparing Baseline Characteristics in the Two Studied Groupsa.
Variable | Ketorolac Group | Ibuprofen Group | P Value |
---|---|---|---|
Gender | 0.78 | ||
Female | 41 (34.2) | 39 (32.5) | |
Male | 79 (65.8) | 81 (67.5) | |
Age, y | 38.7 ± 13.0 | 38.7 ± 11.6 | 0.56 |
History of kidney stone | 0.40 | ||
No | 81 (67.5) | 87 (72.5) | |
Yes | 39 (32.5) | 33 (27.5) | |
Vital signs | |||
Body temperature, °C | 37.8 ± 0.5 | 37.8 ± 0.4 | 0.89 |
Systolic blood pressure, mmHg | 117.0 ± 9.8 | 117.2 ± 8.5 | 0.86 |
Diastolic blood pressure, mmHg | 73.6 ± 7.6 | 74.0 ± 6.7 | 0.65 |
Heart rate, /min | 77.3 ± 6.3 | 76.6 ± 6.0 | 0.38 |
Respiratory rate, /min | 15.6 ± 1.6 | 15.7 ± 1.6 | 0.83 |
Stone size, mm | 5.5 ± 2.5 | 5.4 ± 2.4 | 0.73 |
Stone location | 0.13 | ||
Unknown | 10 (8.3) | 8 (6.7) | |
Calice | 12 (10.0) | 19 (15.8) | |
Ureter | 72 (60.0) | 72 (60.0) | |
Bladder | 9 (7.5) | 14 (11.7) | |
Calice + ureter | 17 (14.2) | 7 (5.8) | |
Pain severity on admission (VAS) | 8.0 ± 1.2 | 7.8 ± 1.2 | 0.32 |
Abbreviation: VAS, visual analogue scale.
aValues are expressed as mean ± SD or frequency (%).